Get started

Bestsignals

Money maker signal. Hello trenders, No Rsi, Macd, Volume and momentum will be needed to understand this money maker token. Although is not adviced investments with more than 3 numbers, now in the accumulation period all you can buy is treasure. Just observe before buying, will be the same cycle over and over. This is a long term invesment (12 or more months), with a very high risk. Good luck. M.M.M Make Motherfuc.in Money Be wise: don´t work for the money, make your money work for you.
FTX:ADABEARUSDLong
by DeFontain
1
$CASI KST Buy Signal CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical products and various therapeutics in China, the United States, and internationally. The company's product pipeline includes EVOMELA, a melphalan hydrochloride for injection primarily for use as a high-dose conditioning treatment prior to hematopoietic progenitor cell transplantation in patients with multiple myeloma. Its product pipeline also comprise CNCT19, an autologous CD19 CAR-T investigative product for the treatment of patients with B-cell acute lymphoblastic leukemia (B-ALL) and B-cell non-Hodgkin lymphoma; CID-103, an anti-CD38 monoclonal antibody being for the treatment of patients with multiple myeloma; ZEVALIN, a CD20-directed radiotherapeutic antibody, to treat patients with NHL; and Thiotepa, a chemotherapeutic agent, which has multiple indications including use as a conditioning treatment for use prior to hematopoietic stem cell transplantation. In addition, the company offers MARQIBO, a microtubule inhibitor, approved by the FDA for the treatment of adult patients with Philadelphia chromosome-negative ALL; and Octreotide LAI formulations for the treatment of acromegaly and for the control of symptoms associated with various neuroendocrine tumours, as well as developing a portfolio of 25 FDA-approved abbreviated new drug applications. It has licensing agreements with Black Belt Therapeutics Limited; Juventas Cell Therapy Ltd.; Pharmathen Global BV; and Cleave Therapeutics, Inc. The company was formerly known as EntreMed, Inc. and changed its name to CASI Pharmaceuticals, Inc. in June 2014. CASI Pharmaceuticals, Inc. was founded in 1991 and is based in Rockville, Maryland.
NASDAQ:CASILong
by UnknownUnicorn19246015
GBPJPY - The bulls are in control eyeing more gainsTrend Analysis: The GBPJPY currency pair on the 4 hours chart has been in an uptrend since 04 February 2020 when it registered the lowest price level of the period under study at 140.910. Since then, the currency pair has been successfully forming higher tops and higher bottoms. At time of writing, the GBPJPY is moving around 143.245 above the 20-period and 40-period simple moving average respectively. This reveals the buyers’ determination to pull the exchange rate of GBPJPY to higher levels. Additionally, the oscillator analysis indicates positive sentiment for the GBPJPY. The 14 period RSI Oscillator (Relative Strength Index) is above the 50 level - a fact that shows that the buyers are in control of the market. The 23 period Momentum Oscillator is also above the 100 mark, which illustrates bullish movement in the currency pair. When attaching the Fibonacci Retracement tool from the top at 142.877 and dragging it to the bottom at 142.133, three price targets may be calculated. The first target level is projected at 143.337 (161.8%), which has been successfully reached. The second target level is estimated at 144.081 (261.8%). The third target level is forecasted at 145.285 (423.6.8%). It remains to be seen how much lower the bears will manage to push the price of the GBPJPY.
Long
by UnknownUnicorn6646720
GBPAUD - is surging to higher levelsTrend Analysis: The GBPAUD currency pair on the 4 hours chart has been in an uptrend since 23 December 2019 when it registered the lowest price level of the period under study at 1.86504. Since then, the currency pair has been successfully forming higher tops and higher bottoms. At time of writing, the GBPAUD is moving around 1.94164 below the 20-period and 40-period simple moving average respectively. This reveals the buyers’ determination to pull the exchange rate of GBPAUD to higher levels. Additionally, the oscillator analysis indicates positive sentiment for the GBPAUD. The 14 period RSI Oscillator (Relative Strength Index) is above the 50 level - a fact that shows that the buyers are in control of the market. The 23 period Momentum Oscillator is also above the 100 mark, which illustrates bullish movement in the currency pair. When attaching the Fibonacci Retracement tool from the top at 1.93149 and dragging it to the bottom at 1.92372, three price targets may be calculated. The first target level is projected at 1.93629 (161.8%), which has been successfully reached. The second target level is estimated at 1.94406 (261.8%). The third target level is forecasted at 1.95663 (423.6.8%). It remains to be seen how much lower the bears will manage to push the price of the GBPAUD.
Long
by UnknownUnicorn6646720